Effects of Dapagliflozin on Progression of Alport Syndrome
Clinical trial NCT06226896 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06226896
- Sponsor
- Nanjing University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-15
- Primary completion
- 2026-06-30
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.